High-Throughput CRISPR Screening in Hematological Neoplasms

SIMPLE SUMMARY: High-throughput CRISPR screening provides an unbiased way for functional genomic studies in hematological malignancies. This approach has been used to study different blood cancers aiming to identify modulator genes for drug efficacy, therapeutic targets, synthetic lethal interaction...

Descripción completa

Detalles Bibliográficos
Autores principales: Ancos-Pintado, Raquel, Bragado-García, Irene, Morales, María Luz, García-Vicente, Roberto, Arroyo-Barea, Andrés, Rodríguez-García, Alba, Martínez-López, Joaquín, Linares, María, Hernández-Sánchez, María
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9329962/
https://www.ncbi.nlm.nih.gov/pubmed/35892871
http://dx.doi.org/10.3390/cancers14153612

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9329962/
https://www.ncbi.nlm.nih.gov/pubmed/35892871
http://dx.doi.org/10.3390/cancers14153612

Ejemplares similares